A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT00951665 · COMPLETED
Trial details
- NCT number
- NCT00951665
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2012-02-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.